Cyclezyme (CYCLE) Q1 2026 earnings summary

Executive summary

• Focused on developing enzymatic solutions for PET plastic recycling, aiming for a circular and sustainable plastics economy.

• Achieved a key milestone with the grant of its first European patent for enzymatic depolymerization using microwaves.

• Advanced partnerships for scaling up recycling technology, targeting low-grade PET streams currently sent to incineration.

• Continued collaboration with industrial partners and expanded enzyme applications to nylon-based materials.

Financial highlights

• Net sales for Q1 2026 were 0 KSEK, down from 150 KSEK in Q1 2025.

• Operating loss widened to -825 KSEK from -347 KSEK year-over-year.

• Net loss after tax was -833 KSEK, compared to -359 KSEK in Q1 2025.

• Cash flow for the period was -764 KSEK, with cash and cash equivalents at 1,819 KSEK as of March 31, 2026.

• Equity per share was 2.67 SEK, and the equity ratio stood at 86.7%.

Outlook and guidance

• Management expects current financial resources, cost adjustments, and ongoing projects to support operations for at least 12 months from the balance sheet date.

• Ongoing focus on technology development, process optimization, and scaling with industrial partners.